CDG Therapeutics Inc, 1317 Jackson Ave, River Forest, IL 60305, US

Capstone Development Services is an innovative shared services development company specializing in the development and regulatory approval of complex generic pharmaceuticals and medical devices. With a strong focus on partnerships with global pharmaceutical and medical companies, Capstone has successfully developed and gained regulatory approvals for over 20 healthcare products in the United States, European Union, and Canada, offering new and affordable healthcare solutions to the market. Established by strategic healthcare investor Water Street Healthcare Partners, Capstone is led by a dedicated executive team, including President and CEO Daniel S. Robins, Ph.D., Chief Commercial Officer Peter Karas, and Chief Business Officer and CFO Ellen Hoffing. The company's heritage dates back to 2013 when it was founded, and it has since expanded its portfolio with the establishment of various subsidiaries, including Celerity Pharmaceuticals, Gage Development Company, Balmoral Medical, Long Grove Pharmaceuticals, Orchard Medical Development, and Loop Therapeutics.Generated from the website